Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nutriband Inc WT
(NQ:
NTRBW
)
1.050
-0.180 (-14.63%)
Streaming Delayed Price
Updated: 3:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nutriband Inc WT
< Previous
1
2
3
4
Next >
Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement
October 27, 2022
Via
ACCESSWIRE
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology
October 26, 2022
Via
ACCESSWIRE
Nutriband Inc. Invited to Present at the 2023 Transdermal and Microneedle Conference in London on January 23 and 24
October 17, 2022
Via
ACCESSWIRE
Nutriband With Kindeva Drug Delivery Demonstrate Enhanced Abuse-Deterrent Characteristics for AVERSA(TM) Fentanyl
October 04, 2022
Via
ACCESSWIRE
Nutriband Inc. Reports Revenue Up 113% YoY in Q2
September 08, 2022
Via
ACCESSWIRE
Nutriband Inc. Announces Application for Dual Listing on Upstream
October 03, 2022
Via
ACCESSWIRE
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
September 15, 2022
Via
ACCESSWIRE
Nutriband Inc. Provides Update on Seven-for-Six Forward Stock Split
August 16, 2022
Via
ACCESSWIRE
Nutriband Inc. Details of Seven-for-Six Forward Stock Split
August 10, 2022
Via
ACCESSWIRE
Nutriband Receives Notice of Allowance from the Canadian Intellectual Property Office for its AVERSA(TM) Abuse Deterrent Transdermal Technology Patent
August 01, 2022
Via
ACCESSWIRE
Nutriband Inc. Announces Seven-for-Six Forward Stock Split
July 27, 2022
Via
ACCESSWIRE
Nutriband Inc. Announces Seven-for-Six Forward Stock Split
July 27, 2022
ORLANDO, FL / ACCESSWIRE / July 27, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) ("Nutriband" or the "Company") announced today that its Board of Directors has approved and declared a 7:6 forward...
From
Nutriband Inc.
Via
AccessWire
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company
July 26, 2022
Via
ACCESSWIRE
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company
July 26, 2022
ORLANDO, FL / ACCESSWIRE / July 26, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that it has received the Final Judgment in favor of the company, effectively allowing the company...
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. Registers New Company Branch in Ecuador with Plans to Expand into the South American Market
July 22, 2022
Via
ACCESSWIRE
Nutriband Inc. Registers New Company Branch in Ecuador with Plans to Expand into the South American Market
July 22, 2022
ORLANDO, FL / ACCESSWIRE / July 22, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) is pleased to announce the opening of its new branch in Quito, Ecuador. The Company plans to expand its product...
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
July 21, 2022
Via
ACCESSWIRE
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
July 21, 2022
ORLANDO, FL / ACCESSWIRE / July 21, 2022 / RedChip Companies will air a new interview with Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), on The RedChip Money Report® on Bloomberg TV, this Saturday, July...
From
RedChip
Via
AccessWire
Nutriband Inc. Successfully Obtains Court Verdict for Recovery of Shares Constituting 15% of Its Total Outstanding Shares
July 15, 2022
ORLANDO, FL / ACCESSWIRE / July 15, 2022 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that it has received a verdict in favor of the company, where the company prevailed on all issues,...
From
Nutriband Inc.
Via
AccessWire
Topics
Lawsuit
Exposures
Financial
Legal
Nutriband Supports Update to CDC Opioid Prescribing Guidelines
June 03, 2022
New proposed guidelines reiterate need for abuse deterrent technologies and call for enabling clinicians to provide comprehensive pain management including appropriate use of opioid medications
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. Interview to Air on Bloomberg U.S. on The Redchip Money Report(R)
May 27, 2022
ORLANDO, FL / ACCESSWIRE / May 27, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, contract research and development...
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
May 20, 2022
Nutriband Inc. Invites Individual and Institutional Investors As Well as Advisors and Analysts, To Attend Its Real-Time, Interactive Presentation at the Emerging Growth Conference
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May
May 17, 2022
ORLANDO, FL / ACCESSWIRE / May 17, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today it has booked nearly a quarter of a million dollars in new in contract manufacturing orders through...
From
Nutriband Inc.
Via
AccessWire
Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiology Tape Product
May 11, 2022
Class 1 Medical Device Registration Allows Nutriband To Explore New Product Manufacturing Opportunities Through Its Wholly Owned Subsidiary Active Intelligence LLC ORLANDO, FL / ACCESSWIRE / May 11,...
From
Nutriband Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System’ Published by the United States Patent and Trademark Office Following Recent Issuance Notice
February 16, 2022
ORLANDO, FL / ACCESSWIRE / February 16, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that the United States Patent and Trademark Office (USPTO) has published its patent titled...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. To Participate in The Benzinga All Access Event on February 4
February 04, 2022
ORLANDO, FL / ACCESSWIRE / February 4, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) will be participating in the Benzinga ALL ACCESS, which will take place on February 4. Nutriband CEO, Gareth...
From
Nutriband Inc.
Via
AccessWire
Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and Trademark Office
January 28, 2022
ORLANDO, FL / ACCESSWIRE / January 28, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the receipt of an Issue Notification from the United States Patent and Trademark Office (USPTO)...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology
January 18, 2022
ORLANDO, FL / ACCESSWIRE / January 18, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced an expanded product development pipeline for its proprietary AVERSA™ abuse deterrent transdermal...
From
Nutriband Inc.
Via
AccessWire
Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
January 10, 2022
ORLANDO, FL / ACCESSWIRE / January 10, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the signing of a feasibility agreement with Kindeva Drug Delivery to develop Nutriband's lead...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment by Leading Healthcare Consulting Firm
January 05, 2022
ORLANDO, FL / ACCESSWIRE / January 5, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products has completed the market assessment...
From
Nutriband Inc.
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.